Albumin is a necessary stabilizer of TBE-vaccine to avoid fever in children after vaccination
- 16 October 2001
- Vol. 20 (3-4) , 532-537
- https://doi.org/10.1016/s0264-410x(01)00329-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Can we reduce the dose of a vaccine?Controlled Clinical Trials, 1997
- Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre studyVaccine, 1996
- Differential regulation of tumour necrosis factor‐α mRNA degradation in macrophages by interleukin‐4 and interferon‐γImmunology, 1996
- TUMOR NECROSIS FACTOR: A Pleiotropic Cytokine and Therapuetic TargetAnnual Review of Medicine, 1994
- Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST‐1European Journal of Immunology, 1993
- The Biology of Interleukin-6 (Part 1 of 2)Published by S. Karger AG ,1992
- Superantigens: Mechanism of T-Cell Stimulation and Role in Immune ResponsesAnnual Review of Immunology, 1991
- A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response studyVaccine, 1990
- Mediators in the Pathogenesis of Toxic Shock Syndrome: OverviewClinical Infectious Diseases, 1989
- Experimenteller und epidemiologischer Beitrag zur aktiven Immunisierung gegen die Fr hling-Sommer-ZeckenencephalitisArchiv für die gesamte Virusforschung, 1941